Citation Impact
Citing Papers
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
2017
Chimeric Antigen Receptor Therapy
2018 Standout
Works of Ta-Ming Liu being referenced
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
2015